| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 03/21/2007 | CN1305522C Rat acarpous medicine and its preparation method |
| 03/21/2007 | CN1305498C Chinese medicinal ointment for treating mammary glands hyperplasia |
| 03/21/2007 | CN1305484C Externally used Chinese traditional medicine for treating mastopathy |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 03/20/2007 | US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192959 Sodium channel blockers |
| 03/20/2007 | US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |
| 03/20/2007 | US7192956 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative |
| 03/20/2007 | US7192942 Wet milling while crystallizing to obtain a primary particle suspension. |
| 03/20/2007 | US7192940 Ether compounds |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192768 Improving the viability and pregnancy potential of oocytes and pre-embryos obtained in connection with in vitro maturation, in vitro fertilization and pre-embryo transfer treatment |
| 03/20/2007 | US7192607 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |
| 03/15/2007 | WO2007030537A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
| 03/15/2007 | WO2007030362A1 Ikk inhibitors for the treatment of endometriosis |
| 03/15/2007 | WO2007030360A2 P13k inhibitors for the treatment of endometriosis |
| 03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | WO2007029340A1 Method of using aloe powder in sexual intercourse as lubricant having lubricity |
| 03/15/2007 | WO2006135638A3 Tanaproget compositions containing ethinyl estradiol |
| 03/15/2007 | WO2006114422A3 Use of devil's claw (harpagophytum procumbens) root extracts for endometriosis treatment |
| 03/15/2007 | WO2003068169A3 Stabilized synthetic immunogen delivery system |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060568 5HT2c receptor modulators |
| 03/15/2007 | US20070059298 Method for administering a vaginal care composition |
| 03/15/2007 | US20070059290 Transcriptional regulation of target genes |
| 03/15/2007 | CA2621470A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | CA2621057A1 Ikk inhibitors for the treatment of endometriosis |
| 03/15/2007 | CA2620164A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
| 03/15/2007 | CA2618489A1 Pi3k inhibitors for the treatment of endometriosis |
| 03/14/2007 | EP1761513A1 Tetracyclic compounds as estrogen ligands |
| 03/14/2007 | EP1761252A1 Matrix-controlled transdermal therapeutic system based on an adhesive for administering norelgestromin or the combination thereof with an estrogen |
| 03/14/2007 | EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/14/2007 | EP1406897B1 Compounds |
| 03/14/2007 | EP1347764B1 Gel composition based on alcohol for the treatment of hypogonadism through transscrotal application |
| 03/14/2007 | EP1242083B1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 03/14/2007 | EP1226169B1 Molecular structure of rhd negative locus |
| 03/14/2007 | EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| 03/14/2007 | EP1067956B1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/14/2007 | EP0998471B1 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 03/14/2007 | CN1930146A Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists |
| 03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
| 03/14/2007 | CN1927390A Compound recipe interferon vaginal spray for preventing and treating human viral infection |
| 03/14/2007 | CN1927370A Baofukang vaginal soft capsule and its preparing process |
| 03/14/2007 | CN1927359A Drug for treating endometriosis |
| 03/14/2007 | CN1927326A Nutritious health food for improving man sexual function and antifatigue and method for making same |
| 03/14/2007 | CN1927324A Preparation method of traditional medicine preparation for treating women's menoxenia |
| 03/14/2007 | CN1927323A Drug for treating women's climacteric complex |
| 03/14/2007 | CN1927314A Decoction drug for treating blood stasis type climacteric hysteromyoma and concurrent metrorrhagia and preparing method thereof |
| 03/14/2007 | CN1927296A Chinese medicine composition for treating cervical and lumbar disc disease |
| 03/14/2007 | CN1927294A Water free flower red drug administration system and preparing technique |
| 03/14/2007 | CN1927288A Preparing art of cassia twig and Tuckahoe composition and use thereof |
| 03/14/2007 | CN1927264A Medicinal composition for treating menoxenia and preparation process thereof |
| 03/14/2007 | CN1927246A Medicament for animals with heat clearing and detoxicating, detumescence and obstruction removing functions and preparing method thereof |
| 03/14/2007 | CN1927244A Traditional Chinese medicine soft capsule for curing gynaecologic disease and its preparing technology |
| 03/14/2007 | CN1927215A Nifuratel-nystatin vaginal gel and method for preparing same |
| 03/14/2007 | CN1927213A Nifuratel-nystatin vaginal effervescent-tablets |
| 03/14/2007 | CN1304377C Metalloproteinase inhibitors |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/14/2007 | CN1304043C Longhedan pills and their preparation |
| 03/14/2007 | CN1304038C Medicinal composition for treating elytritis, preparation and its quality control method |
| 03/14/2007 | CN1304030C Medicine for menstrual disorder and leukorrhagia |
| 03/14/2007 | CN1304026C Paste for treating impotience and its making method |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/14/2007 | CN1304002C Vaginal effervescence tablet of secnidazole and its preparation |
| 03/14/2007 | CN1303998C Pharmaceutical formulations containing darifenacin |
| 03/14/2007 | CN1303981C Preparation method of Fuyankang medicine for treating gynecopathy |
| 03/13/2007 | US7189812 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 03/13/2007 | US7189756 Pyrrolidine derivatives |
| 03/13/2007 | US7189755 Pyrrolidine melanocortin-specific compounds |
| 03/13/2007 | US7189754 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
| 03/13/2007 | US7189720 Selective NPY (Y5) antagonists |
| 03/13/2007 | US7189719 Sodium channel blockers |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2387533C Purine derivatives |
| 03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
| 03/13/2007 | CA2171111C Inhibition of urinary calculi growth |
| 03/12/2007 | CA2559510A1 Compositions and methods for reducing vaginal ph |
| 03/12/2007 | CA2559407A1 Anhydrous composition containing an acid-acid buffer system |
| 03/08/2007 | WO2007027477A2 Treating vulvodynia using prodrugs of gaba analogs |
| 03/08/2007 | WO2007026725A2 Drug, drug gudance system, magnetic detection system, and drug design method |
| 03/08/2007 | WO2007025349A1 Modulating ovulation and growth rates |
| 03/08/2007 | WO2006121968A3 Method for treatment of uterine fibroid tumors |
| 03/08/2007 | WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain |
| 03/08/2007 | US20070054950 3-Azabicyclo[3.1.0]hexane derivatives |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054882 Male anti-fertility agents |
| 03/08/2007 | US20070054312 Human transmembrane proteins |
| 03/07/2007 | EP1759734A2 Aromatase inhibition to enhance assisted reproduction |
| 03/07/2007 | EP1759701A2 Buproprion Metabolites and Methods of Their Synthesis and Use. |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | EP1758910A1 Substituted triazole derivatives as oxytocin antagonists |